Nazca acquires a majority stake in Diater, pioneer in immunotherapy treatments for allergy, in a deal valued at €45 million

by Nazca Capital

NAZCA CAPITAL –one of the leading mid-market private equity funds in Spain– has reached an agreement (through Nazca Fund IV) with Ferrer to acquire its stake in DIATER, a Spanish biopharmaceutical...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Latest transactions in the Data Analytic...

by Baker Tilly

There have been a number of strategic acquisitions of companies in the...

Photos Stream